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VASOPILESSIN MODULATES SYMPATHETIC NERVE ACTIVTIY 
IN VARIOUS MODELS OF HYPERTENSION. F Muders, D Eisner, U 
Balmer, K Jandoleit, GAJ RIegger, M Pulkovits. Klinik und Polikli,ulk 
Inhere Medizin II, University of Regenshurg; Germany 
Central vasopressin (AVP) plays an important role in the control of 
blood pressure and heart rate in hyperteusion. AVP stimulates 
sympathetic outflow via the locus coeruleus (LC) which receives 
vasopressinergic unervation and microinjeetJon of AVP in the LC 
produces an increase in blood pressure and heart rate. 
In order to investigste the functional status of AVP in the LC we 
determinad the AVP content in the LC (micropunch technique) in 5 
different models of bypertension (SI-I~ DOCA salt, Angintensin II 
infusions using osmotic minipumps, IC1K, 1C2K) in the rat. Elevated 
blood pressure levels (tail cuff method) wcr¢ comparable in all models 
used (160 + 13 mmI-Ig). In comparison toconsols (53 + 9 pg/mg protein) 
AVP was significantly elevated in the LC of rats with genetic 
hypertension (SHR; +60%; p<0.05) and in the lC2K model (+172%), 
whereas in AII induced hypert~asive- and DOCA- rats AVP was 
significantiy suppressed in the LC (- 39,2 % and -44.8 % vs. CTRL, 
respeodvely. In rats with ICIK induced hypertension the AVP was 
unchanged. 
Conclusion: In the two models (SFIR and IC2K), which nre both 
characterized by elevated sympathetic nerve activity, high endogenous 
AVP were demonstrated in the LC. In the other models (ALl], DOCA, 
1C1K) rats showed unaltered or suppressed AVP content in the LC which 
may reduce sympathetic outflow and counteract to a further increase of 
blood pressure. 
Our results support he hypothesis that ca~tral vasopressin modulates 
sympathetic nerve activity via the locus coeruleus. 
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ROLE OF THE SYMPATHETIC NERVOUS SYSTEM 
DURING THE DEVELOPMENT OF OBESITY-INDUCED 
HYPERTENSION IN RABBITS. V Antic, F Klener-Belforti, A 
Templnl, BN Van Viler and JP Montani*. Institute of 
Physiology, Unlvereity of Frlbourg, Switzerland, and 
Memorial University of Newfoundland, St, John's,  Canada. 
We have previously reported that weight gain induced by high 
fat diet (HFD) leads to an increase in mean arterial pressure 
(MAP, +14%) and heart rate (HR, +31%) in the adult rabbit. We 
tested the hypothesis that an increased activity of the 
sympathetic nervous system is involved in the development of 
obesity-induced hypertension. A combination of &[~ sympathetic 
blockers (terezosin/proprenolol, 15-25 mg/kg/day each, in the 
drinking water) was chronically administered to rabbits housed in 
customized metabolic cages for daily measurement of urine 
output and continuous monitoring of arterial pressure by 
telemetry, 24 hr a day. The degree of sympathetic blockade was 
assessed by testing the MAP and HR reactivity to intravenous 
sympathetic agonists. After the first two weeks of treatment with 
sympathetic blockers under control diet (Control ~/[~), animals 
were switched to HFD for the following six weeks. HFD induced 
a progressive increase in body weight (BW), but no rise in MAP 
and only a small increase in HR as shown in the Table (n=5). A 
slight rise in glomerular filtration rate (GFR) was observed under 
~./~, blockers and was further potentiated under HFD. 
Period MAP HR BW GFR 
(mmHg) (bpm) (kg) (ml/min) 
Before ~J[3 66.1 +2.1 202-+4 4.3-+0.1 10.2_+0.8 
Control o~ 63.9:1:1.9 194 -+ 5 4.4 ± 0.1 12.2 ± 1.3 
HFD-Wk I 65.4-+ 2.0 213-+4 4.7-+0.2 13.2_+1.7 
HFD-Wk 2 65.2-+1.4 213-+5 4.9-+0.2 13.9-+1.0 
HFD-Wk 3 65.0-+ 1.0 213_+6 5.1 -+0.2 14.1 -+0.9 
HFD-Wk 4 64.3-+1.1 213±6 5.2-+0.2 13.5-+0.8 
HFD-Wk 6 63.8-+1.3 222-+8 5.4-+0.2 14.4-+1.1 
Time-control animals fed normal diet showe d no changes in MAP 
or HR under long-term treatment with ~J[~ blockers. 
Our results indicate that the activation of the sympathetic 
nervous system may play an important role in the pathogenesis 
of obesity-induced hypertension. 
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THE KINETICS OF Na*-H* ANTIPORTER ACTIVITY IN PLATELETS 
OF DAHL-IWAI SALT SENSITIVE RATS. K Otsuka 1, K Shibagald 2, Y 
Ohna 2, M Hayashi 2 and T Saruta *z. Tokyo Senbai HospitaP, Department 
of Internal Medicine, Keio University 2, Tokyo, Japan. 
We have previously shown that altered intracellular Ca 2. metabolism 
is associated with sodium-induced hypertension in Dabl-lwai salt 
sensitive (DS) rets(Otsuka K et aL Am J Hypertens 1997; 10:1396-'1403). 
Altered intracellular Ca 2. metabolism and increased Na*-H* antiporter 
activity have been demonstrated in the blood cells of hypertensive 
subjects. However, few reports have investigated the Na*-H* antiporter 
activity in the blood cells of sodium-induced hypertension. Therefore, we 
characterized the kinetics of Na*-H* antiperter activity in platelets of DS 
rats. Intraceltular pH (pHi) was determined in plntelet suspensions using 
2,7-biscarboxyethyl-5(6)-carboxyfluorescein tetraacetoxymethyl ester, a 
fluorescent pH indicator. The kinetics properties of Na*-H* antiperter 
activity were determined using pletelets acidified with nigedcin and 
challenged with varying extracellular concentrations of Na ÷. Initial rate 
(IR) of phi change was estimated by the following equation: 
phil = pHi~ - [pHi~ - pHial x e "*t in which pHi.t is pHi at given time t, 
pHi~ is phi at new steady state, pHi e is the initial phi at the moment of 
activation of the Na*-H* antiport, and k is the rate constant. IRs were 
then used to estimate the kinetic parameters of the Na*-H* antiporter, 
according to the following model: 
V = V TM x [Na*] "  I I~s" + [Na*] "  in which V is the lR of pHi 
recovery, V "~ is the maximal IR, Ke s is the [Na*] corresponding to half- 
maximal activation, and n is the Hill coefficient. DS rats were fed either a 
0.3% NaCI diet (N=6)or an 8% NaCI diet (N=5) from 5 to 9 weeks of age. 
Although there was not a statistically significant effect of sodium on 
(2.07-+.27 vs 2.25±.27A pH/min,P=.65) and Ko.s (56.7-+ 1.9 vs 52.7--- + 
2.1raM, P=.20), Ke s was inversely correlated with systolic blood pressure 
(r~. 133,P=-.03). This study demonstrated the kinetics of pletelet Na*-H ÷ 
antiporter activity of DS rats for the first time, and the altered kinetics of 
Na*-H* antiporter activity was elucidated to be involved in the 
pathogenesis of the experimental model of sodium-induced 
hypertension. 
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ADRENOMEDULLIN REDUCES THE RISK FOR 
PULMONARY HYPERTENSION IN RATS. P. Viiav. J.W. 
Brown and T.G. Sharp. Indiana University School of Medicine, 
Indianapolis, IN 46202 
Pulmonary hypertension (PH) is a progressive condition that may 
result in right ventricle failure and death. Injury to the pulmonary 
vaaculature may lead to an imbalance inthe levels of vasoactive 
mediators uch as endethelin-I (ET-I) and adrenomedullin (ADM), 
a newly identified 52-amino acid hyporensive peptide. 
To evaluate the effects of ADM on the development of PH, we 
treated 14 Sprague Dawley rats with 60 mg/kg monocretaline 
(MC). Control rats received solvent alone (n=10). During n 3-week 
induction period, group I rats received no treatment, group II rats 
(n=7) received ADM (30 nmol) on alternate days and group Ill rats 
(n=7) received ADM for 3 days prior to testing. Plasma ET-I and 
ADM levels were measured as follows: 
C 
MC 
ET-I Levels (ng/ml) ADM Levels (pg/ml) 
I II Ill I It Ill 
0.4-+0.1 0.3±'0.1 0.3:1:0.1 4.4-+1,3 2.7i0.1 6.6~.8 
4.3i'0.5 2.8:~.3 2.3:£0.5 [ 9.8-+1,8 4.3±0.2 [ 7.3:£0.7 
When PH is induced by MC in mrs, ET- 1 rises significantly 
(p<0.05 in all groups). Elevation of ADM in control animals 
suggests its role in compensating forvasoconstriction produced by 
ET-I. ADM Ueatmant reduced ET-I significantly (p<0.05 group I
vs either II or III) in the other animals. ADM levels were highest in 
the control aulnuds (,p< 0.05 C vs MC). The lower levels efADM 
in groups II and llI could be the result of increased ¢lcerance of 
ADM, suppreasiou of andoganous release of ADM or a reduction in 
the extent of MC induced vascular endothelial damage. 
We conclude that ADM tranmtent bhmts the rise in ET-I during 
the development of PH and may act through different mechanisms 
depending on the time of administratiou. 
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